Skip to main content
Premium Trial:

Request an Annual Quote

Spanish Researchers Sequence Antibiotic-Resistant Outbreak Bacteria on 454


This article has been updated to correct the location of LifeSequencing.

Researchers from Madrid's Hospital Universitario La Paz Research Institute have sequenced the genomes of three antibiotic-resistant strains of Klebsiella pneumoniae that were isolated from a recent outbreak in a Spanish hospital.

The team sequenced the strains on the 454 GS FLX+ system using Valencia-based service provider LifeSequencing. The sequencing data was assembled using 454's GS De Novo Assembler software and functional annotation was performed with Era 7 Bioinformatics' BG7 system.

The three strains showed an "increasing resistance pattern to a wide range of the antibiotics most commonly used at the hospital," according to a statement.

The researchers now plan to compare the genomes to help understand how antibiotic resistance evolves. Additionally, they will compare the outbreak strains to non-pathogenic strains that are commonly found in the human gut and intestine to try and figure out what makes the organism pathogenic.

"Fast and affordable sequencing of pathogenic bacteria is a huge qualitative and quantitative advance that is radically changing the way researchers and clinicians view the infectious disease process," Jesús Mingorance, lead researcher at the Hospital Universitario La Paz, said in a statement.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.